Attached files

file filename
EX-16.1 - LETTER, DATED JULY 13, 2016, FROM EISNERAMPER LLP TO THE SECURITIES AND EXCHANGE COMMISSION. - Silo Pharma, Inc.f8k071216ex16i_pointcapital.htm

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, DC 20549

 

FORM 8-K

 

CURRENT REPORT

 

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): July 12, 2016

 

POINT CAPITAL, INC.

(Exact name of registrant as specified in its charter)

 

Delaware   333-167386   90-0554260
(State or other jurisdiction
of incorporation)
  (Commission File Number)   (IRS Employer
Identification No.)

 

285 Grand Avenue, Building 5, Englewood, New Jersey   07631
(Address of principal executive offices)   (Zip Code)

 

Registrant’s telephone number, including area code (201) 408-5126

 

 

 

(Former name or former address, if changed since last report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

 Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

 Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

 Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

 Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 

 

 

 

 

Section 4. Matters Related to Accountants and Financial Statements

 

Item 4.01. Changes in Registrant’s Certifying Accountant.

 

On July 12, 2016, Point Capital, Inc. (the “Registrant”) was informed by EisnerAmper LLP ("Eisner") that it was not standing for reappointment as the Registrant’s independent registered public accounting firm for the year ending December 31, 2016.

 

The Termination of Eisner

 

Eisner was the independent registered public accounting firm for the Registrant from March 5, 2014 until July 12, 2016. None of Eisner's reports on the Registrant’s financial statements for the years ended December 31, 2015 and December 31, 2014 (a) contained an adverse opinion or disclaimer of opinion, or (b) was modified as to uncertainty, audit scope, or accounting principles other than as provided below, or (c) contained any disagreements on any matters of accounting principles or practices, financial statement disclosure, or auditing scope or procedures, which disagreements, if not resolved to the satisfaction of Eisner, would have caused it to make reference to the subject matter of the disagreements in connection with its reports. None of the reportable events set forth in Item 304(a)(1)(iv) of Regulation S-K occurred during the period in which Eisner served as the Registrant’s principal independent accountants.

 

During our two most recent fiscal years and the subsequent interim period preceding the termination of Eisner, we had no disagreements with the firm on any matter of accounting principles or practices, financial statement disclosure, or auditing scope of procedure which disagreement if not resolved to the satisfaction of Eisner would have caused it to make reference to the subject matter of the disagreement in connection with its report.

 

The Registrant has provided Eisner with a copy of this disclosure and has requested that Eisner furnish it with a letter addressed to the Securities and Exchange Commission stating whether it agrees with the above statements, and if not, stating the respects in which it does not agree. A copy of the letter from Eisner addressed to the Securities and Exchange Commission dated July 13, 2016 is filed as Exhibit 16.1 to this Current Report on Form 8-K.

 

Item 9.01 Financial Statements and Exhibits.

 

(d)     Exhibits.

 

Exhibit No.   Description
     
16.1   Letter, dated July 13, 2016, from EisnerAmper LLP to the Securities and Exchange Commission.

 

 2 
 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

  POINT CAPITAL, INC.
     
Date: July 14, 2016 By: /s/ Eric Weisblum
  Name: Eric Weisblum
  Title: President and Chief Executive Officer

 

 

3